Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 6—June 2004
Research

Antimicrobial Resistance among Campylobacter Strains, United States, 1997–2001

Amita Gupta*Comments to Author , Jennifer M. Nelson*, Timothy J. Barrett*, Robert V. Tauxe*, Shannon P. Rossiter*, Cindy R. Friedman*, Kevin W. Joyce*, Kirk E. Smith†, Timothy F. Jones‡, Marguerit A. Hawkins§, Beletshachew Shiferaw¶, James L. Beebe#, Duc J. Vugia**, Terry Rabatsky-Ehr††, James A. Benson‡‡, Timothy P. Root§§, Frederick J. Angulo*, and for the NARMS Working Group
Author affiliations: *Centers for Disease Control, Atlanta, Georgia, USA; †Minnesota Department of Health, St. Paul, Minnesota, USA; ‡Tennessee Department of Health, Nashville, Tennessee, USA; §Maryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA; ¶Oregon Department of Human Services, Portland, Oregon, USA; #Colorado Department of Public Health & Environment, Denver, Colorado, USA; **California Department of Health Services, Sacramento, California, USA; ††Connecticut Department of Public Health, Hartford, Connecticut, USA; ‡‡Georgia Department of Human Services, Atlanta, Georgia, USA; §§New York State Department of Health, Albany, New York, USA

Main Article

Table 1

Antimicrobial resistance among Campylobacter isolates by species, NARMS 1997–2001

% Resistant
Antimicrobial
 C. jejuni (n = 1,471)
 C. coli (n = 63)
 C. upsaliensis (n = 7)
 C. lari (n = 2)
 C. fetus (n = 5)
 Undetermineda (n = 5 )
 Total (n = 1,553)
Azithromycinb
 2
 9
 0
 0
 0
 0
 2
Chloramphenicol
 0.3
 5
 0
 0
 0
 40
 0.6
Ciprofloxacin
 16
 30c
 14
 0
 0
 0
 16
Clindamycin
 1
 9
 0
 0
 0
 20
 2
Erythromycin
 2
 8
 0
 0
 0
 20
 2
Gentamicinb
 0
 2
 0
 0
 0
 0
 0.1
Nalidixic acid
 17
 36c
 14
 100
 80
 20
 18
Tetracycline 43 43 0 0 20 0 43

aUndetermined isolates were hippurate-negative Campylobacter that could not be further speciated with available polymerase chain reaction primers.
bFor azithromycin and gentamicin, only 1,336 isolates were tested.
cComparison of proportion of resistant C. coli to resistant C. jejuni was statistically significant for ciprofloxacin and nalidixic acid but not tetracycline (p < 0.01)

Main Article

1This isolate was reported to be ciprofloxacin resistant in reference

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external